CA1262907C - - Google Patents

Info

Publication number
CA1262907C
CA1262907C CA 403789 CA403789A CA1262907C CA 1262907 C CA1262907 C CA 1262907C CA 403789 CA403789 CA 403789 CA 403789 A CA403789 A CA 403789A CA 1262907 C CA1262907 C CA 1262907C
Authority
CA
Canada
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA 403789
Other versions
CA1188218A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to CA000475098A priority Critical patent/CA1262907A/en
Publication of CA1188218A publication Critical patent/CA1188218A/en
Application granted granted Critical
Publication of CA1262907C publication Critical patent/CA1262907C/xx
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K4/00Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/834Urine; urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA000403789A 1981-07-02 1982-05-26 PURIFIED ANTINEOPLASTIC FRACTIONS AND METHODS OF TREATMENT OF NEOPLASMS Expired CA1188218A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000475098A CA1262907A (en) 1981-07-02 1985-02-25 3-¬n-phenylacetylaminopiperidine|-2,6 dion and process of synthesizing same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27972881A 1981-07-02 1981-07-02
US06/330,383 US4470970A (en) 1981-07-02 1981-12-15 Purified antineoplaston fractions and methods of treating neoplastic disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA000475098A Division CA1262907A (en) 1981-07-02 1985-02-25 3-¬n-phenylacetylaminopiperidine|-2,6 dion and process of synthesizing same

Publications (2)

Publication Number Publication Date
CA1188218A CA1188218A (en) 1985-06-04
CA1262907C true CA1262907C (de) 1989-11-14

Family

ID=26959856

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000403789A Expired CA1188218A (en) 1981-07-02 1982-05-26 PURIFIED ANTINEOPLASTIC FRACTIONS AND METHODS OF TREATMENT OF NEOPLASMS

Country Status (14)

Country Link
US (1) US4470970A (de)
EP (1) EP0069232B1 (de)
JP (3) JPH0729925B2 (de)
AU (1) AU551109B2 (de)
CA (1) CA1188218A (de)
DE (1) DE3273952D1 (de)
DK (2) DK162813C (de)
ES (1) ES8502417A1 (de)
HK (1) HK30289A (de)
IL (1) IL65960A (de)
MY (1) MY102918A (de)
NO (1) NO163595C (de)
NZ (1) NZ200805A (de)
SG (1) SG4489G (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559325A (en) * 1981-12-15 1985-12-17 Burzynski Stanislaw R Purified antineoplaston fractions and methods of treating neoplastic disease
US4593038A (en) * 1985-04-03 1986-06-03 Burzynski Stanislaw R Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
US4705796A (en) * 1986-08-25 1987-11-10 Stereochemical Genetics, Inc. Use of 3-N-phenylacetylamino-2,6-piperidinedione for treatment of neuropsychiatric disorders
AU7742491A (en) * 1990-04-12 1991-11-11 Stereo-Chemical Genetics, Inc. Synthetic piperidinediones with cytostatic activity
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5089508A (en) * 1990-09-04 1992-02-18 Burzynski Stanislaw R Methods for treating aids
US5116622A (en) * 1990-09-12 1992-05-26 Burzynski Stanislaw R Methods for treating parkinson's disease
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US6037376A (en) * 1991-10-21 2000-03-14 The United States Of America As Represented By The Department Of Health And Human Services Methods for therapy of cancer
EP0567613B1 (de) * 1991-10-21 2002-02-20 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Zusammensetzungen zur behandlung und vorbeugung von krebs
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
US5783605A (en) * 1995-02-27 1998-07-21 Kuo; Sheng-Chu Helper inducers for differentiation therapy and chemoprevention of cancer
CA2254772C (en) * 1996-05-14 2004-01-27 Stanislaw R. Burzynski Liposomal antineoplaston therapies with markedly improved antineoplastic activity
EP2298350A3 (de) * 1996-07-26 2011-06-08 Susan P. Perrine Zusammensetzung enthaltend einen induzierenden wikstoff und einen antiviralen wirkstoff zur behandlung von viralen störungen
US6258849B1 (en) * 1998-07-23 2001-07-10 Stanislaw R. Burzynski Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
US6127419A (en) * 1998-11-23 2000-10-03 Burzynski; Stanislaw R. Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
AU1553799A (en) * 1998-12-18 2000-07-12 Chang, Ming-Lieh Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
US6987131B1 (en) * 2000-06-26 2006-01-17 Burzynski Stanislaw R Phenylacetic acid compositions for treating or preventing hypercholesterolemia
NZ538405A (en) * 2002-08-01 2007-12-21 Aesgen Inc Improved treatment of cancer with glutamine and carbohydrate
US7087219B2 (en) * 2003-05-28 2006-08-08 Stanislaw R. Burzynski Toothpaste containing anticancer agents
US20060246016A1 (en) * 2003-05-28 2006-11-02 Burzynski Stanislaw R Toothpaste containing anticancer agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE463549A (de) *
GB2003887A (en) * 1977-09-06 1979-03-21 Nyegaard & Co As Isolation of peptides from urine
JPS57115330A (en) * 1981-01-08 1982-07-17 Toshiba Mach Co Ltd Forming process for thick plastic products and its metal mold
JP2897285B2 (ja) * 1989-10-19 1999-05-31 東洋紡績株式会社 熱可塑性樹脂フィルム積層物

Also Published As

Publication number Publication date
AU8423982A (en) 1983-01-06
US4470970A (en) 1984-09-11
NO163595C (no) 1990-06-27
NO163595B (no) 1990-03-19
JPH0780764B2 (ja) 1995-08-30
ES512894A0 (es) 1985-01-01
EP0069232B1 (de) 1986-10-29
HK30289A (en) 1989-04-21
DK242082A (da) 1983-01-03
JPS5810521A (ja) 1983-01-21
NO822218L (no) 1983-01-03
CA1188218A (en) 1985-06-04
IL65960A0 (en) 1982-09-30
JPH0739390B2 (ja) 1995-05-01
ES8502417A1 (es) 1985-01-01
JPH0558886A (ja) 1993-03-09
SG4489G (en) 1989-05-26
JPH0532548A (ja) 1993-02-09
DK143491D0 (da) 1991-08-06
JPH0729925B2 (ja) 1995-04-05
NZ200805A (en) 1986-08-08
EP0069232A2 (de) 1983-01-12
DK162813B (da) 1991-12-16
DE3273952D1 (en) 1986-12-04
DK143491A (da) 1991-08-06
IL65960A (en) 1985-11-29
MY102918A (en) 1993-03-31
EP0069232A3 (en) 1984-07-04
AU551109B2 (en) 1986-04-17
DK162813C (da) 1992-05-04

Similar Documents

Publication Publication Date Title
FR2499026B1 (de)
DE3249822A1 (de)
DE3103321C2 (de)
FR2499947B3 (de)
DE3249714A1 (de)
FR2500006B1 (de)
DE3248040C2 (de)
FR2497467B1 (de)
FR2498672B1 (de)
DE3229269C2 (de)
FR2498264B1 (de)
FR2499326B1 (de)
FR2499972B1 (de)
DE3106138C2 (de)
FR2500334B3 (de)
DE3139502C2 (de)
DE3225633C2 (de)
DE3128978C2 (de)
FR2498418B3 (de)
DE3145804C2 (de)
DE3304302C2 (de)
FR2499954B3 (de)
DE3150782C2 (de)
DE3202031C2 (de)
DE3229789C2 (de)

Legal Events

Date Code Title Description
MKEX Expiry